scholarly journals ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease

2015 ◽  
Vol 112 (50) ◽  
pp. E7003-E7012 ◽  
Author(s):  
Vasco Sequeira ◽  
Aref Najafi ◽  
Paul J. M. Wijnker ◽  
Cristobal G. dos Remedios ◽  
Michelle Michels ◽  
...  
Keyword(s):  
Thin Filament ◽  
Thick Filament ◽  
Actin Binding ◽  
Mutant Proteins ◽  
Force Development ◽  
Myosin Binding Protein ◽  
Myosin Binding Protein C ◽  
Filament Activation ◽  
Myosin Binding ◽  
Highly Correlated

Diastolic dysfunction is general to all idiopathic dilated (IDCM) and hypertrophic cardiomyopathy (HCM) patients. Relaxation deficits may result from increased actin–myosin formation during diastole due to altered tropomyosin position, which blocks myosin binding to actin in the absence of Ca2+. We investigated whether ADP-stimulated force development (without Ca2+) can be used to reveal changes in actin–myosin blockade in human cardiomyopathy cardiomyocytes. Cardiac samples from HCM patients, harboring thick-filament (MYH7mut, MYBPC3mut) and thin-filament (TNNT2mut, TNNI3mut) mutations, and IDCM were compared with sarcomere mutation-negative HCM (HCMsmn) and nonfailing donors. Myofilament ADP sensitivity was higher in IDCM and HCM compared with donors, whereas it was lower for MYBPC3. Increased ADP sensitivity in IDCM, HCMsmn, and MYH7mut was caused by low phosphorylation of myofilament proteins, as it was normalized to donors by protein kinase A (PKA) treatment. Troponin exchange experiments in a TNNT2mut sample corrected the abnormal actin–myosin blockade. In MYBPC3trunc samples, ADP sensitivity highly correlated with cardiac myosin-binding protein-C (cMyBP-C) protein level. Incubation of cardiomyocytes with cMyBP-C antibody against the actin-binding N-terminal region reduced ADP sensitivity, indicative of cMyBP-C’s role in actin–myosin regulation. In the presence of Ca2+, ADP increased myofilament force development and sarcomere stiffness. Enhanced sarcomere stiffness in sarcomere mutation-positive HCM samples was irrespective of the phosphorylation background. In conclusion, ADP-stimulated contraction can be used as a tool to study how protein phosphorylation and mutant proteins alter accessibility of myosin binding on actin. In the presence of Ca2+, pathologic [ADP] and low PKA-phosphorylation, high actin–myosin formation could contribute to the impaired myocardial relaxation observed in cardiomyopathies.

scholarly journals Inotropic interventions do not change the resting state of myosin motors during cardiac diastole

2018 ◽  
Vol 151 (1) ◽  
pp. 53-65 ◽  
Author(s):  
Marco Caremani ◽  
Francesca Pinzauti ◽  
Joseph D. Powers ◽  
Serena Governali ◽  
Theyencheri Narayanan ◽  
...  
Keyword(s):  
Protein C ◽  
Thin Filament ◽  
Sarcomere Length ◽  
Binding Protein ◽  
Thick Filament ◽  
Myosin Binding Protein ◽  
Myosin Binding Protein C ◽  
Filament Activation ◽  
Myosin Binding ◽  
Myosin Motors

When striated (skeletal and cardiac) muscle is in its relaxed state, myosin motors are packed in helical tracks on the surface of the thick filament, folded toward the center of the sarcomere, and unable to bind actin or hydrolyze ATP (OFF state). This raises the question of whatthe mechanism is that integrates the Ca2+-dependent thin filament activation, making myosin heads available for interaction with actin. Here we test the interdependency of the thin and thick filament regulatory mechanisms in intact trabeculae from the rat heart. We record the x-ray diffraction signals that mark the state of the thick filament during inotropic interventions (increase in sarcomere length from 1.95 to 2.25 µm and addition of 10−7 M isoprenaline), which potentiate the twitch force developed by an electrically paced trabecula by up to twofold. During diastole, none of the signals related to the OFF state of the thick filament are significantly affected by these interventions, except the intensity of both myosin-binding protein C– and troponin-related meridional reflections, which reduce by 20% in the presence of isoprenaline. These results indicate that recruitment of myosin motors from their OFF state occurs independently and downstream from thin filament activation. This is in agreement with the recently discovered mechanism based on thick filament mechanosensing in which the number of motors available for interaction with actin rapidly adapts to the stress on the thick filament and thus to the loading conditions of the contraction. The gain of this positive feedback may be modulated by both sarcomere length and the degree of phosphorylation of myosin-binding protein C.

scholarly journals C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation

2016 ◽  
Vol 113 (6) ◽  
pp. 1558-1563 ◽  
Author(s):  
Samantha P. Harris ◽  
Betty Belknap ◽  
Robert E. Van Sciver ◽  
Howard D. White ◽  
Vitold E. Galkin
Keyword(s):  
Protein C ◽  
Thin Filament ◽  
Molecular Motor ◽  
Binding Protein ◽  
Myosin Binding Protein ◽  
Myosin Binding Protein C ◽  
Genes Encoding ◽  
Myosin Subfragment 1 ◽  
Filament Activation ◽  
Myosin Binding

Mutations in genes encoding myosin, the molecular motor that powers cardiac muscle contraction, and its accessory protein, cardiac myosin binding protein C (cMyBP-C), are the two most common causes of hypertrophic cardiomyopathy (HCM). Recent studies established that the N-terminal domains (NTDs) of cMyBP-C (e.g., C0, C1, M, and C2) can bind to and activate or inhibit the thin filament (TF). However, the molecular mechanism(s) by which NTDs modulate interaction of myosin with the TF remains unknown and the contribution of each individual NTD to TF activation/inhibition is unclear. Here we used an integrated structure–function approach using cryoelectron microscopy, biochemical kinetics, and force measurements to reveal how the first two Ig-like domains of cMyPB-C (C0 and C1) interact with the TF. Results demonstrate that despite being structural homologs, C0 and C1 exhibit different patterns of binding on the surface of F-actin. Importantly, C1 but not C0 binds in a position to activate the TF by shifting tropomyosin (Tm) to the “open” structural state. We further show that C1 directly interacts with Tm and traps Tm in the open position on the surface of F-actin. Both C0 and C1 compete with myosin subfragment 1 for binding to F-actin and effectively inhibit actomyosin interactions when present at high ratios of NTDs to F-actin. Finally, we show that in contracting sarcomeres, the activating effect of C1 is apparent only once low levels of Ca2+ have been achieved. We suggest that Ca2+ modulates the interaction of cMyBP-C with the TF in the sarcomere.

scholarly journals During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation

2009 ◽  
Vol 185 (6) ◽  
pp. 1083-1095 ◽  
Author(s):  
Shenhav Cohen ◽  
Jeffrey J. Brault ◽  
Steven P. Gygi ◽  
David J. Glass ◽  
David M. Valenzuela ◽  
...  
Keyword(s):  
Ubiquitin Ligase ◽  
Protein C ◽  
Thin Filament ◽  
Muscle Wasting ◽  
Ring Finger ◽  
Thick Filament ◽  
Myosin Binding Protein ◽  
Myosin Binding Protein C ◽  
Associated Proteins ◽  
Myosin Binding

Loss of myofibrillar proteins is a hallmark of atrophying muscle. Expression of muscle RING-finger 1 (MuRF1), a ubiquitin ligase, is markedly induced during atrophy, and MuRF1 deletion attenuates muscle wasting. We generated mice expressing a Ring-deletion mutant MuRF1, which binds but cannot ubiquitylate substrates. Mass spectrometry of the bound proteins in denervated muscle identified many myofibrillar components. Upon denervation or fasting, atrophying muscles show a loss of myosin-binding protein C (MyBP-C) and myosin light chains 1 and 2 (MyLC1 and MyLC2) from the myofibril, before any measurable decrease in myosin heavy chain (MyHC). Their selective loss requires MuRF1. MyHC is protected from ubiquitylation in myofibrils by associated proteins, but eventually undergoes MuRF1-dependent degradation. In contrast, MuRF1 ubiquitylates MyBP-C, MyLC1, and MyLC2, even in myofibrils. Because these proteins stabilize the thick filament, their selective ubiquitylation may facilitate thick filament disassembly. However, the thin filament components decreased by a mechanism not requiring MuRF1.

scholarly journals SKELETAL MyBP-C ISOFORMS TUNE THE MOLECULAR CONTRACTILITY OF DIVERGENT SKELETAL MUSCLE SYSTEMS

2019 ◽  
Author(s):  
Amy Li ◽  
Shane Nelson ◽  
Sheema Rahmanseresht ◽  
Filip Braet ◽  
Anabelle S. Cornachione ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Thin Filament ◽  
Thick Filament ◽  
Muscle Contractility ◽  
Myosin Binding Protein ◽  
Myosin Binding Protein C ◽  
N Terminus ◽  
Slow Type ◽  
Myosin Binding ◽  
Slow Twitch

ABSTRACTSkeletal muscle myosin-binding protein C (MyBP-C) is a myosin thick filament-associated protein; localized through its C terminus to distinct regions (C-zones) of the sarcomere. MyBP-C modulates muscle contractility, presumably through its N terminus extending from the thick filament and interacting with either the myosin head region and/or the actin thin filament. Two isoforms of MyBP-C (fast- and slow-type) are expressed in a muscle-type specific manner. Are the expression, localization, and Ca2+-dependent modulatory capacities of these isoforms different in fast-twitch extensor digitorum longus (EDL) and slow-twitch soleus (SOL) muscles derived from Sprague-Dawley rats? By mass spectrometry, four MyBP-C isoforms (one fast-type MyBP-C and three N-terminally spliced slow-type MyBP-C) were expressed in EDL but only the three slow-type MyBP-C isoforms in SOL. Using EDL and SOL native thick filaments in which the MyBP-C stoichiometry and localization are preserved, native thin filament sliding over these thick filaments showed that only in the C-zone, MyBP-C Ca2+-sensitizes the thin filament and slows thin filament velocity. These modulatory properties depended on MyBP-C’s N-terminus, as N-terminal proteolysis attenuated MyBP-C’s functional capacities. To determine each MyBP-C isoform’s contribution to thin filament Ca2+-sensitization and slowing in the C-zone, we used a combination of in vitro motility assays using expressed recombinant N-terminal fragments and in silico mechanistic modeling. Our results suggest that each skeletal MyBP-C isoform’s N terminus is functionally distinct and has modulatory capacities that depend on the muscle-type in which they are expressed, providing the potential for molecular tuning of skeletal muscle performance through differential MyBP-C expression.SIGNIFICANCEMyosin-binding protein C (MyBP-C) is a critical component of the skeletal muscle sarcomere, muscle’s smallest contractile unit. MyBP-C’s importance is evident by genetic mutations leading to human myopathies, such as distal arthrogryposis (i.e. club foot). However, the molecular basis of MyBP-C’s functional impact on skeletal muscle contractility is far from certain. Complicating matters further is the expression of fast- and slow-type MyBP-C isoforms that depend on whether the muscle is fast- or slow-twitch. Using multi-scale proteomic, biophysical and mathematical modeling approaches, we define the expression, localization, and modulatory capacities of these distinct skeletal MyBP-C isoforms in rat skeletal muscles. Each MyBP-C isoform appears to modulate muscle contractility differentially; providing the capacity to fine-tune muscle’s mechanical performance as physiological demands arise.

Cardiac myosin binding protein-C phosphorylation accelerates β-cardiac myosin detachment rate in mouse myocardium

2021 ◽  
Author(s):  
Bertrand C.W. Tanner ◽  
Michael J. Previs ◽  
Yuan Wang ◽  
Jeffrey Robbins ◽  
Bradley M. Palmer
Keyword(s):  
Protein C ◽  
Binding Protein ◽  
Cardiac Contraction ◽  
Power Stroke ◽  
Cardiac Myosin ◽  
Force Development ◽  
Myosin Binding Protein ◽  
Myosin Binding Protein C ◽  
Detachment Rate ◽  
Myosin Binding

Cardiac myosin binding protein-C (cMyBP-C) is a thick filament protein that modulates cardiac contraction-relaxation through its phosphorylation. Phosphorylation of cMyBP-C and ablation of cMyBP-C have been shown to increase the rate of MgADP release in the acto-myosin crossbridge cycle in the intact sarcomere. The influence of cMyBP-C on Pi-dependent myosin kinetics has not yet been examined. We investigated the effect of cMyBP-C and its phosphorylation on myosin kinetics in demembranated papillary muscle strips bearing the b-cardiac myosin isoform from non-transgenic (NTGβ) and transgenic mice lacking cMyBP-C (t/tβ). We used quick stretch and stochastic length-perturbation analysis to characterize rates of myosin detachment and force development over 0-12 mM Pi. Protein kinase-A (PKA) treatment was applied to half the strips to probe the effect of cMyBP-C phosphorylation on Pi-sensitivity of myosin kinetics. Increasing Pi increased myosin crossbridge detachment rate similarly for muscles with and without cMyBP-C, although these rates were higher in muscle without cMyBP-C. Treating myocardial strips with PKA accelerated detachment rate when cMyBP-C was present over all Pi, but not when cMyBP-C was absent. The rate of force development increased with Pi in all muscles. However, Pi sensitivity of the rate force development was reduced when cMyBP-C was present vs. absent, suggesting that cMyBP-C inhibits Pi-dependent reversal of the power stroke or stabilizes crossbridge attachment to enhance the probability of completing the power stroke. PKA treatment reduces the role for cMyBP-C to slow myosin detachment and thus effectively accelerates b-myosin detachment in the intact myofilament lattice.

scholarly journals High-throughput screen using fluorescence lifetime detects compounds that modulate myosin-binding protein C interactions with actin

2021 ◽  
Author(s):  
Thomas A. Bunch ◽  
Piyali Guhathakurta ◽  
Victoria C. Lepak ◽  
Andrew R. Thompson ◽  
Rhye-Samuel Kanassatega ◽  
...  
Keyword(s):  
Heart Failure ◽  
High Throughput ◽  
Fluorescence Lifetime ◽  
Protein C ◽  
Binding Protein ◽  
Actin Binding ◽  
High Throughput Screen ◽  
Myosin Binding Protein ◽  
Myosin Binding Protein C ◽  
Myosin Binding

ABSTRACTCardiac myosin-binding protein C (cMyBP-C) interacts with actin and myosin to modulate cardiac contractility. These interactions are regulated by cMyBP-C phosphorylation. Heart failure patients often have decreased cMyBP-C phosphorylation and phosphorylation in model systems appears to be cardioprotective for heart failure. Therefore, cMyBP-C is a potential target for heart failure drugs that mimic phosphorylation and/or perturb its interactions with actin/myosin.We have used a novel fluorescence lifetime-based assay to identify small-molecule inhibitors of actin-cMyBP-C binding. Actin was labeled with a fluorescent dye (Alexa Fluor 568, AF568) near its cMyBP-C binding sites. When combined with cMyBP-C N-terminal fragment, C0-C2, the fluorescence lifetime of AF568-actin decreases. Using this reduction in lifetime as a readout of actin binding, a high-throughput screen of a 1280-compound library identified 3 reproducible Hit compounds that reduced C0-C2 binding to actin in the micromolar range. Binding of phosphorylated C0-C2 was also blocked by these compounds. That they specifically block binding was confirmed by a novel actin-C0-C2 time-resolved FRET (TR-FRET) binding assay. Isothermal titration calorimetry (ITC) and transient phosphorescence anisotropy (TPA) confirmed that the Hit compounds bind to cMyBP-C but not to actin. TPA results were also consistent with these compounds inhibiting C0-C2 binding to actin. We conclude that the actin-cMyBP-C lifetime assay permits detection of pharmacologically active compounds that affect cMyBP-C’s actin binding function. TPA, TR-FRET, and ITC can then be used to understand the mechanism by which the compounds alter cMyBP-C interactions with actin.

scholarly journals Skeletal myosin binding protein-C isoforms regulate thin filament activity in a Ca2+-dependent manner

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Brian Leei Lin ◽  
Amy Li ◽  
Ji Young Mun ◽  
Michael J. Previs ◽  
Samantha Beck Previs ◽  
...  
Keyword(s):  
Protein C ◽  
Thin Filament ◽  
Binding Protein ◽  
Dependent Manner ◽  
Myosin Binding Protein ◽  
Myosin Binding Protein C ◽  
Skeletal Myosin ◽  
Myosin Binding

The carboxyl terminus of myosin binding protein C (MyBP-C, C-protein) specifies incorporation into the A-band of striated muscle

1996 ◽  
Vol 109 (1) ◽  
pp. 101-111 ◽  
Author(s):  
R. Gilbert ◽  
M.G. Kelly ◽  
T. Mikawa ◽  
D.A. Fischman
Keyword(s):  
Amino Acids ◽  
Protein C ◽  
Binding Protein ◽  
Thick Filament ◽  
Binding Domain ◽  
C Protein ◽  
Amino Terminal ◽  
Myosin Binding Protein ◽  
Myosin Binding Protein C ◽  
Myosin Binding

Myosin binding protein-C (MyBP-C), also known as C-protein, is a major constituent of the thick filaments of vertebrate striated muscles. The protein, approximately 130 kDa, consists of a series of 10 globular motifs (numbered I to X) each of approximately 90–100 amino acids, bearing resemblance to the C2-set of immunoglobins (Ig C2) and to the fibronectin type III (FnIII) motifs. Using pure preparations of myosin and MyBP-C, it has been demonstrated that the major myosin binding domain of MyBP-C resides within the C-terminal Ig C2 motif (motif X). However, in the context of the in vivo thick filament, it is uncertain if the latter domain is sufficient to target MyBP-C correctly to the A-band or if other regions of the molecule are required for this process. To answer this question, cultures of skeletal muscle myoblasts were transfected with expression plasmids encoding seven truncation mutants of MyBP-C, and their targeting to the A-band investigated by immunofluorescence microscopy. To distinguish the recombinant proteins from endogenous MyBP-C, a myc epitope was inserted at each amino terminus. Recombinant MyBP-C exhibited an identical distribution in the sarcomere to that of native MyBP-C; i.e. it was found exclusively in the C-zone of the A-band. A mutant encoding the C-terminal 372 amino acids, but lacking motifs I-VI (termed delta 1–6), also targeted correctly to the A-band. This fragment, which is composed of two Ig C2 and two FnIII motifs, was the minimal protein fragment required for correct A-band incorporation. Larger amino-terminal deletions or deletion of motif X, the myosin binding domain, abolished all localization to the A-band. One construct (delta 10) lacking only motif X strongly inhibited myofibril assembly. We conclude that the myosin binding domain of MyBP-C, although essential, is not sufficient for correct incorporation into the A-band and that motifs VII to IX are required for this process. The data suggest a topological model in which MyBP-C is associated with the thick filament through its C terminus.

Sign in / Sign up

Export Citation Format

Share Document